Previous 10 | Next 10 |
4 Biotech Penny Stocks For Your June Watchlist Are you considering buying penny stocks this June? Trading penny stocks has been extremely popular this year. With low prices and high volatility, the potential for rapid portfolio growth is an exciting prospect for investors to conside...
SEATTLE, June 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announces that it has r...
Ocugen (OCGN) -38% after likely needing additional trial for CovaxinAethlon Medical (AEMD) -16%.Materialise (MTLS) -13% after prices 4M-ADS offering at $24.Celsius Holdings (CELH) -13% after prices equity offering at $62.50.FuelCell Energy (FCEL) -12% o...
Shares of Atossa Therapeutics (NASDAQ: ATOS) were tumbling 22.8% as of 11:36 a.m. EDT on Wednesday. The decline came after the company announced final results from its phase 2 clinical study evaluating oral endoxifen in treating breast cancer with administration between diagnosis an...
Gainers: Aethlon Medical AEMD +425%, Checkpoint Therapeutics CKPT +26%, Adamis Pharmaceuticals ADMP +12%, SCWorx (WORX) +18%, ZIOPHARM Oncology ZIOP +15%.Losers: Atossa Therapeutics ATOS -14%, CEL-SCI CVM -11%, Precipio (PR...
Atossa Therapeutics (ATOS) shares slide more than 17% during premarket trading after the company posted final data from its Phase 2 clinical study of oral Endoxifen in breast cancer.The trial met its main goal and showed a reduction Ki-67, which is a common measure of tumor cell act...
SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced ...
Shares of Atossa Therapeutics Inc. (NASDAQ:ATOS) traded today at $6.82, eclipsing its 52-week high. This new high was reached on below average trading volume as 6.3 million shares traded hands, while the average 30-day volume is approximately 13.1 million shares. Atossa Therapeutics Inc ...
Atossa Therapeutics (NASDAQ: ATOS) got off to a roaring start this week, with its stock closing just over 30% higher on Monday to reach a new one-year peak. The company announced that clinical results for a promising pipeline drug are coming in a matter of days. Atossa, a clinic...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Atossa Therapeutics (NASDAQ: ATOS ) and ATOS stock are seeing a lot of green. Shares of ATOS stock are up approximately 27% at the time of writing on very heavy volume. Source: Shutte...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...